import Link from "next/link";
import JsonLd from "@/components/JsonLd";
import PageDisclaimer from "@/components/PageDisclaimer";
import PageTOC from "@/components/PageTOC";
import ContactLink from "@/components/ContactLink";
import AmazonCTAButton from "@/components/AmazonCTAButton";
import { buildPageMetadata } from "@/lib/seo";

export const metadata = buildPageMetadata({
  path: "/supplements/quercetin",
  title: "Quercetin: Senolytic Flavonoid + Zinc Ionophore Anti-Inflammatory",
  description:
    "Quercetin dosing, bioavailability (phytosome > standard), the senolytic dasatinib + quercetin combination, and how it stacks with anti-inflammatory peptides like KPV.",
});

const faqs = [
  {
    q: "What's a senolytic, and is quercetin actually one?",
    a: "Senolytics are compounds that selectively kill senescent cells — the 'zombie cells' that accumulate with age, resist normal apoptosis, and release a toxic inflammatory cocktail (SASP — senescence-associated secretory phenotype) that drives age-related tissue dysfunction. Quercetin is one of the most-studied natural senolytics, typically paired with the prescription drug dasatinib (D+Q combination) in Mayo Clinic aging-research protocols. As a standalone senolytic at typical supplemental doses, quercetin's effect is modest; the D+Q combination at therapeutic doses (dasatinib 100 mg + quercetin 1,000 mg for 2 consecutive days, then off for 2 weeks) is what produces measurable senescent-cell clearance in human pilot trials.",
  },
  {
    q: "Standard quercetin vs phytosome vs isoquercetin — which form?",
    a: "Bioavailability is the central practical issue, similar to curcumin. Standard quercetin (the cheap powder/capsule form) has poor oral absorption — single-digit percent bioavailability. Quercetin phytosome (Quercefit) is bound to phosphatidylcholine and absorbs ~20× better than standard. Isoquercetin (the glucoside form found in onions and other foods) absorbs ~3× better than standard quercetin via SGLT1 transporter. Practical default: Quercefit phytosome for senolytic and longevity protocols where serum quercetin matters; isoquercetin as a middle-cost option; standard quercetin powder is essentially placebo at typical supplemental doses (unless you're using gram-doses to compensate).",
  },
  {
    q: "How much quercetin should I take?",
    a: "Depends on goal and form. For general anti-inflammatory and antihistamine use: 500–1,000 mg/day of Quercefit phytosome (or 1,500–2,500 mg/day standard quercetin with bromelain to enhance absorption). For senolytic protocols: the Mayo Clinic D+Q pilot used dasatinib 100 mg + quercetin 1,000 mg for 2 consecutive days, repeated every 2 weeks (intermittent rather than daily). For cardiovascular/blood pressure use: 500 mg/day phytosome shows benefit per meta-analyses. Antiviral protocols typically use 500–1,000 mg/day phytosome plus 15–30 mg elemental zinc to leverage the zinc ionophore mechanism.",
  },
  {
    q: "Why pair quercetin with zinc and bromelain?",
    a: "Two different reasons. Zinc + quercetin pairing leverages quercetin's zinc ionophore mechanism — quercetin facilitates zinc transport across cell membranes, increasing intracellular zinc concentrations. Zinc inhibits RNA-dependent RNA polymerase used by many viruses for replication, which is the mechanistic basis for the antiviral pairing. Bromelain + quercetin pairing improves quercetin's oral absorption — bromelain (a pineapple-derived protease) enhances bioavailability through proteolytic action in the gut. Most antiviral and immune-support formulas pair all three (quercetin + zinc + bromelain) for this reason.",
  },
  {
    q: "Can I stack quercetin with KPV for anti-inflammatory effects?",
    a: (
      <>
        Yes — the stack is mechanistically natural for users targeting comprehensive inflammation modulation.{" "}
        <Link href="/peptides/kpv" className="text-[#3A759F] hover:underline">KPV</Link>{" "}
        (lysine-proline-valine, the C-terminal tripeptide of α-MSH) is an anti-inflammatory peptide that reduces tissue inflammation via melanocortin pathway and MC1R/MC5R receptor binding — particularly useful for gut inflammation, IBD adjunct support, and topical skin applications. Quercetin operates at a different layer: NF-κB and NLRP3 inflammasome inhibition reduce systemic inflammatory gene expression, plus senolytic clearance of pro-inflammatory senescent cells. The peptide does direct melanocortin-pathway anti-inflammation; quercetin handles the broader NF-κB/NLRP3 and senolytic arms. Mechanistically complementary, no known negative interactions. For users targeting longevity rather than acute inflammation,{" "}
        <Link href="/peptides/nad-plus" className="text-[#3A759F] hover:underline">NAD+ peptide</Link>{" "}
        is the natural longevity-cluster pairing instead — supports the sirtuin pathway quercetin&apos;s AMPK/mTOR mechanism overlaps with.
      </>
    ),
  },
  {
    q: "Quercetin for allergies — does it really work?",
    a: "Yes, with modest but real evidence. Quercetin inhibits histamine release from mast cells and reduces inflammatory mediator production in allergic responses. Several small trials show modest improvements in seasonal allergic rhinitis symptoms with 500–1,000 mg/day, particularly when paired with bromelain. Effect sizes are smaller than for second-generation antihistamines (cetirizine, fexofenadine, loratadine) — quercetin won't replace those for moderate-to-severe allergies. As an adjunct for users with mild allergies or seeking a more natural approach, quercetin is a reasonable trial.",
  },
  {
    q: "Is the antiviral zinc-ionophore claim real?",
    a: "Mechanistically yes; clinically uncertain. Quercetin demonstrably facilitates zinc transport into cells in vitro, and zinc inhibits viral RNA-dependent RNA polymerase. The mechanism is biochemically established. Clinical outcomes data in humans for specific viral infections (including the high-profile COVID-19 research from 2020–2022) is mixed — some positive small trials, some null. The honest framing: quercetin + zinc is a mechanism-backed antiviral adjunct with thinner clinical evidence than the marketing suggests. Reasonable to use as one component of an immune-support protocol; not a replacement for antiviral medications when indicated.",
  },
  {
    q: "How long does it take to notice quercetin's effects?",
    a: "Anti-inflammatory and antihistamine effects: typically 1–2 weeks of consistent dosing. Blood pressure effects: 4–6 weeks per meta-analyses. Senolytic protocols are intermittent (not daily) and the cellular clearance effects emerge over months of repeated 2-day-on cycles. Standalone subjective effects are mild for most users — quercetin is more of a background longevity/inflammation modulator than a stimulant or fast-acting compound. If you've taken Quercefit phytosome at 500–1,000 mg/day for 8 weeks with no perceived effect on your target endpoint, quercetin probably isn't your lever for that specific issue.",
  },
];

const studies = [
  {
    title: "Senolytics in Idiopathic Pulmonary Fibrosis: Results from a First-in-Human, Open-Label, Pilot Study",
    authors: "Justice JN, Nambiar AM, Tchkonia T, et al.",
    journal: "EBioMedicine",
    year: "2019",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/30616998/",
    summary: "A first-in-human open-label pilot trial of the dasatinib + quercetin (D+Q) senolytic combination in 14 patients with idiopathic pulmonary fibrosis. D+Q (100 mg dasatinib + 1,000 mg quercetin daily for 3 days/week, 3 cycles over 3 weeks) significantly improved physical function (6-minute walk distance, gait speed, chair stand test) versus baseline. The Justice 2019 trial is the foundational first-in-human evidence for the D+Q senolytic protocol and the basis for subsequent clinical-trial development in aging-related diseases.",
  },
  {
    title: "Senolytics Decrease Senescent Cells in Humans: Preliminary Report from a Clinical Trial of Dasatinib plus Quercetin in Individuals with Diabetic Kidney Disease",
    authors: "Hickson LJ, Langhi Prata LGP, Bobart SA, et al.",
    journal: "EBioMedicine",
    year: "2019",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/31542391/",
    summary: "An open-label pilot trial of dasatinib + quercetin (3-day pulse: 100 mg dasatinib + 1,000 mg quercetin daily) in 9 patients with diabetic kidney disease. Documented reduction in senescent cell burden in skin and adipose tissue biopsies 11 days after treatment, along with reduction in SASP (senescence-associated secretory phenotype) markers in skin and plasma. The Hickson 2019 trial is the cleanest mechanistic evidence that the D+Q protocol actually clears senescent cells in living humans — supporting the senolytic-clearance hypothesis that drives the entire field.",
  },
  {
    title: "Effects of Quercetin Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials",
    authors: "Serban MC, Sahebkar A, Zanchetti A, et al.",
    journal: "Journal of the American Heart Association",
    year: "2016",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/27405810/",
    summary: "A systematic review and meta-analysis of 7 RCTs (n=587) of quercetin supplementation on blood pressure. Quercetin significantly reduced systolic blood pressure (-3.04 mmHg) and diastolic blood pressure (-2.63 mmHg) versus placebo, with greater effect at doses ≥500 mg/day. The Serban 2016 meta-analysis is the cleanest cardiovascular-outcome summary for quercetin and supports the antihypertensive-adjunct use case in pre-hypertensive and mildly hypertensive populations.",
  },
  {
    title: "Quercetin: A Promising Flavonoid for Therapeutic Interventions in Aging and Age-Related Diseases",
    authors: "Hussain SA, Sulaiman AA, Alhaddad H, Alhadidi Q",
    journal: "Current Pharmaceutical Design",
    year: "2021",
    access: "Paywalled",
    url: "https://pubmed.ncbi.nlm.nih.gov/33023444/",
    summary: "A comprehensive review of quercetin's mechanisms and therapeutic potential in aging and age-related diseases. Covers senolytic activity, NF-κB and NLRP3 inflammasome inhibition, AMPK/mTOR signaling, mitochondrial protection, and clinical evidence across cardiovascular, neurodegenerative, and metabolic applications. Useful as a single-source reference for the quercetin evidence landscape in longevity-adjacent contexts.",
  },
  {
    title: "Quercetin and Its Anti-Allergic Immune Response",
    authors: "Mlcek J, Jurikova T, Skrovankova S, Sochor J",
    journal: "Molecules",
    year: "2016",
    access: "Open Access",
    url: "https://pubmed.ncbi.nlm.nih.gov/27187333/",
    summary: "A review of quercetin's mechanisms in allergic and inflammatory responses, covering mast cell stabilization, histamine release inhibition, IgE-mediated response modulation, and clinical evidence in seasonal allergic rhinitis and asthma. Effect sizes are modest but consistent across small trials. Useful as the mechanistic and evidence reference for the antihistamine use case.",
  },
];

const sections = [
  {
    id: "mechanism",
    title: "How does quercetin work?",
    intro:
      "Quercetin works through multiple parallel mechanisms — senolytic (selective killing of senescent cells via PI3K/AKT and BCL-2/BCL-XL inhibition), NF-κB and NLRP3 inflammasome inhibition (broad anti-inflammatory effect), mast cell stabilization (antihistamine), zinc ionophore activity (facilitates intracellular zinc transport — antiviral implications), and AMPK activation / mTOR inhibition (longevity pathways). Bioavailability is the central practical constraint; standard quercetin is poorly absorbed without bioavailability enhancement.",
    body: [
      "Senolytic mechanism. Quercetin selectively inhibits anti-apoptotic survival pathways (PI3K/AKT, BCL-2/BCL-XL) that senescent cells depend on for survival — making them susceptible to programmed cell death while leaving normal cells unaffected. The Mayo Clinic D+Q (dasatinib + quercetin) combination is the most-studied senolytic protocol in human clinical trials; Hickson 2019 documented actual senescent-cell clearance in skin and adipose tissue biopsies after pulsed D+Q dosing.",
      "NF-κB and NLRP3 inflammasome inhibition. Quercetin inhibits NF-κB (master inflammatory transcription factor) and the NLRP3 inflammasome — a key driver of sterile chronic inflammation associated with aging. This dual anti-inflammatory mechanism distinguishes quercetin from simpler antioxidants and supports its use across inflammation-driven conditions.",
      "Mast cell stabilization and antihistamine. Quercetin inhibits histamine release from mast cells and reduces IgE-mediated allergic inflammatory responses. This is the mechanism underlying the modest clinical effects in seasonal allergic rhinitis at 500–1,000 mg/day.",
      "Zinc ionophore activity. Quercetin facilitates zinc transport across cell membranes via interaction with cellular zinc transporters, increasing intracellular zinc concentrations. Zinc inhibits viral RNA-dependent RNA polymerase — the mechanistic basis for the antiviral pairing (quercetin + zinc) commonly used in immune-support protocols.",
      "AMPK activation and mTOR inhibition. Quercetin activates AMPK and inhibits mTOR — two key longevity signaling pathways also modulated by rapamycin, metformin, and caloric restriction. This is the mechanistic basis for quercetin&apos;s positioning as a longevity-adjacent intervention beyond the senolytic arm.",
      "Bioavailability problem. Standard quercetin has poor oral absorption (single-digit percent bioavailability). Quercetin phytosome (Quercefit) is bound to phosphatidylcholine and absorbs ~20× better; isoquercetin (glucoside form) absorbs ~3× better via SGLT1 transporter. Bioavailability formulation choice is the dominant practical variable.",
    ],
  },
  {
    id: "research",
    title: "What does quercetin actually do?",
    intro:
      "Quercetin has multiple distinct evidence arms — senolytic (small but mechanistically meaningful human pilot trials), cardiovascular/blood pressure (modest meta-analytic support), antihistamine (modest small-trial evidence), and antiviral (mechanism strong, clinical outcomes mixed). The senolytic arm is the most mechanistically novel and where the field is moving.",
    body: [
      "Senolytic clearance (Emerging-Moderate). Hickson 2019 documented actual senescent-cell clearance in human skin and adipose tissue biopsies after D+Q treatment. Justice 2019 in idiopathic pulmonary fibrosis showed functional improvements. Sample sizes are small (n=9–14); larger trials are in progress. Mechanistic evidence is strong.",
      "Blood pressure reduction (Moderate). Serban 2016 meta-analysis (7 RCTs, n=587) documented significant SBP (-3.04 mmHg) and DBP (-2.63 mmHg) reductions with quercetin supplementation. Effect strongest at doses ≥500 mg/day. Useful adjunct in pre-hypertensive and mildly hypertensive populations.",
      "Anti-inflammatory biomarkers (Moderate). Reductions in CRP, IL-6, TNF-α documented across multiple trials. Anti-inflammatory effect is mechanistically well-supported by the NF-κB/NLRP3 inhibition pathway.",
      "Antihistamine and seasonal allergic rhinitis (Moderate). Mlcek 2016 review covers mast cell stabilization mechanism and clinical evidence. Effect sizes are modest relative to second-generation antihistamines but real. Useful adjunct for mild allergies.",
      "Antiviral activity (Mixed). Mechanistic case is strong (zinc ionophore + zinc&apos;s RNA polymerase inhibition); clinical outcome data is mixed across viral infections including COVID-19 trials. Most positive trials are small; methodology variable. Reasonable adjunct, not standalone antiviral.",
      "LDL oxidation reduction and lipid profile (Modest). Antioxidant mechanism is well-characterized; clinical lipid-profile improvements are modest in trials.",
      "Athletic performance (Mixed). Some endurance trials show modest improvements in VO2max and time-to-exhaustion; others null. Effect sizes are small relative to caffeine or beta-alanine.",
      "Healthy young-adult longevity transfer (Speculative). The senolytic case is built on age-related disease populations and older adults with measurable senescent-cell burden. Whether quercetin produces meaningful benefit in healthy young adults with intact cellular biology is mechanistically uncertain.",
    ],
  },
  {
    id: "dosing",
    title: "How is quercetin dosed?",
    intro:
      "Quercetin dosing depends on form and goal. Bioavailability is the dominant practical constraint — Quercefit phytosome at 500 mg ≈ 10,000 mg of standard quercetin in serum terms. For senolytic protocols, the Mayo Clinic D+Q pilot used pulsed dosing (2–3 days on, repeated every 2 weeks) rather than daily — but this requires prescription dasatinib.",
    node: (
      <div className="space-y-3">
        <ol className="list-decimal list-inside space-y-1">
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Quercefit phytosome (recommended).</span> 250–500 mg twice daily — equivalent serum quercetin to ~5,000–10,000 mg standard quercetin. Trial-validated for blood pressure and anti-inflammatory effects.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Isoquercetin.</span> 500–1,000 mg/day — ~3× better absorption than standard quercetin via SGLT1 transporter. Middle-ground option.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Standard quercetin + bromelain.</span> 1,000–2,000 mg quercetin + 100–500 mg bromelain daily, with meals. The cheaper option; bromelain enhances absorption via proteolytic action.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Senolytic D+Q protocol (research/clinical).</span> Dasatinib 100 mg + quercetin 1,000 mg for 2–3 consecutive days, repeated every 2 weeks. Dasatinib is prescription-only; the full protocol is clinical research, not self-administration.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Antiviral / immune support.</span> 500–1,000 mg quercetin (phytosome preferred) + 15–30 mg elemental zinc + 100–500 mg bromelain, taken with meals. Standard immune-support combination.</li>
          <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Allergy adjunct.</span> 500–1,000 mg phytosome twice daily, starting 1–2 weeks before allergen exposure season for prophylactic effect.</li>
        </ol>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed pt-2">
          Timeline: anti-inflammatory and antihistamine effects within 1–2 weeks; blood pressure effects 4–6 weeks; senolytic effects are intermittent and dose-cycled. Don&apos;t expect dramatic acute effects from a single dose.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed pt-2">
          <span className="font-semibold">Label math.</span> &ldquo;Quercetin 500 mg&rdquo; standard powder ≈ 50 mg actual serum quercetin (~10% bioavailability). &ldquo;Quercefit phytosome 500 mg&rdquo; ≈ 5,000–10,000 mg standard quercetin equivalent in serum. Read for the bioavailability formulation (Quercefit, isoquercetin) or accept that you&apos;re paying for poorly absorbed standard powder.
        </p>
      </div>
    ),
  },
  {
    id: "how-to-take",
    title: "How to take quercetin",
    intro:
      "Quercetin is taken orally as capsules (the dominant form). Bioavailability formulation choice is the dominant practical variable — standard quercetin underdelivers serum levels at typical doses. The points below cover the details experienced users converge on.",
    node: (
      <div className="space-y-4">
        <div className="overflow-x-auto -mx-4 sm:mx-0">
          <table className="w-full text-base text-left border-collapse border border-[#D9DEE4] dark:border-slate-700 rounded-lg overflow-hidden">
            <thead className="bg-gray-100 dark:bg-[#16181B]">
              <tr>
                <th className="px-4 py-3 font-semibold text-[#16181B] dark:text-slate-100">Aspect</th>
                <th className="px-4 py-3 font-semibold text-[#16181B] dark:text-slate-100">Recommendation</th>
              </tr>
            </thead>
            <tbody className="divide-y divide-gray-200 dark:divide-slate-700">
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Frequency</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">Twice daily preferred (split dosing maintains steadier serum levels). Senolytic D+Q protocol is intermittent (2–3 days on every 2 weeks).</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Best time of day</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">With meals — fat improves absorption (particularly for phytosome). Morning + evening split is the practical default.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Food</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">With fat-containing meals — bioavailability is meaningfully fat-dependent for both standard and phytosome forms. Empty stomach reduces absorption.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Form</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">Quercefit phytosome (best absorption, trial-validated); isoquercetin (mid-tier); standard quercetin + bromelain (budget option). Avoid plain standard quercetin without bromelain — poor absorption.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Standardization marker</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">Look for &ldquo;Quercefit&rdquo; (the patented phytosome formulation from Indena) or &ldquo;quercetin phytosome,&rdquo; &ldquo;isoquercetin,&rdquo; or &ldquo;quercetin + bromelain&rdquo; explicitly. Generic quercetin without bioavailability enhancement is essentially placebo at typical doses.</td>
              </tr>
              <tr className="even:bg-gray-50 dark:even:bg-[#1e293b]/50">
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300 font-medium">Cycling</td>
                <td className="px-4 py-3 text-gray-700 dark:text-slate-300">For chronic anti-inflammatory/cardiovascular use: continuous daily. For senolytic intent: pulsed dosing (2–3 days on every 2 weeks) per the Mayo Clinic protocol. For allergy use: continuous through season.</td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    ),
  },
  {
    id: "stacks",
    title: "What does quercetin stack with?",
    intro:
      "Quercetin pairs naturally with multiple supplement and peptide clusters because its mechanism spans anti-inflammatory, longevity, antiviral, and antihistamine arms. The three areas below cover the natural stacking categories.",
    node: (
      <div className="space-y-5">
        <div>
          <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">With peptides</h3>
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            Quercetin spans two natural peptide-pairing clusters depending on goal.{" "}
            <Link href="/peptides/kpv" className="text-[#3A759F] hover:underline">KPV</Link>{" "}
            (lysine-proline-valine, the C-terminal tripeptide of α-MSH) is an anti-inflammatory peptide that reduces tissue inflammation via melanocortin pathway — particularly useful for gut inflammation, IBD adjunct support, and topical skin applications. Quercetin operates at a different layer: NF-κB and NLRP3 inflammasome inhibition reduce systemic inflammatory gene expression, plus senolytic clearance of pro-inflammatory senescent cells. The peptide does direct melanocortin-pathway anti-inflammation; quercetin handles the broader NF-κB/NLRP3 and senolytic arms.{" "}
            <Link href="/peptides/nad-plus" className="text-[#3A759F] hover:underline">NAD+ peptide</Link>{" "}
            is the natural longevity-cluster pairing — supports the sirtuin pathway quercetin&apos;s AMPK/mTOR mechanism overlaps with. For users pursuing the comprehensive longevity stack:{" "}
            <Link href="/peptides/epitalon" className="text-[#3A759F] hover:underline">Epitalon</Link>{" "}
            adds the pineal-axis arm. Mechanistically complementary across all three peptide cross-links; no known negative interactions.
          </p>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">With supplements</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/zinc" className="text-[#3A759F] hover:underline">Zinc</Link>{" "}
              — leverages quercetin&apos;s zinc ionophore mechanism. Standard immune-support and antiviral pairing.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              Bromelain (100–500 mg) — enhances quercetin&apos;s oral absorption via proteolytic action. Standard quercetin + bromelain stack improves bioavailability of the cheaper form.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/nmn" className="text-[#3A759F] hover:underline">NMN</Link>{" "}
              and{" "}
              <Link href="/supplements/nad-plus" className="text-[#3A759F] hover:underline">NAD+</Link>{" "}
              — longevity-stack co-occupants. Quercetin&apos;s senolytic + AMPK/mTOR arms complement NAD+ supply for sirtuin activation.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/resveratrol" className="text-[#3A759F] hover:underline">Resveratrol</Link>{" "}
              — sirtuin activator. Compatible longevity-stack co-occupant; Sinclair-protocol pairing.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/spermidine" className="text-[#3A759F] hover:underline">Spermidine</Link>{" "}
              — autophagy activator. Different aging-biology arm; common longevity-stack co-occupant.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              Fisetin — closely-related senolytic flavonoid often paired with quercetin in pulsed senolytic protocols.
            </li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              <Link href="/supplements/curcumin" className="text-[#3A759F] hover:underline">Curcumin</Link>{" "}
              — additional NF-κB inhibitor with COX/LOX arms. Compatible anti-inflammatory pairing.
            </li>
          </ol>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">With lifestyle</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Take with fat-containing meals.</span> Bioavailability is meaningfully fat-dependent for both standard and phytosome forms.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Intermittent fasting + senolytic protocol.</span> Senescent-cell clearance may be enhanced by fasting-state autophagy. Pulsed quercetin during fasting windows is mechanistically reasonable, though not directly RCT-validated.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Pre-allergy-season prophylaxis.</span> Starting 1–2 weeks before known seasonal allergen exposure improves the antihistamine effect timing.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Whole-foods quercetin sources.</span> Onions (especially red onions), apples (with skin), capers, berries, leafy greens, green tea. Adequate dietary quercetin from food complements supplemental.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Pre-surgical washout.</span> Stop quercetin 1–2 weeks before scheduled surgery — mild antiplatelet effect plus cytochrome P450 enzyme interference.</li>
          </ol>
        </div>
      </div>
    ),
  },
  {
    id: "side-effects",
    title: "Side effects and interactions",
    intro:
      "Quercetin has a favorable safety profile at typical supplemental doses. The main practical considerations are mild GI effects, cytochrome P450 drug-metabolism interference (clinically meaningful for some medications), and kidney stress at very high chronic doses.",
    node: (
      <div className="space-y-5">
        <div>
          <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">Common (mostly transient)</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Mild GI discomfort — nausea, stomach upset, especially at higher doses or empty stomach. Resolves with food coadministration.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Headache — occasional, generally mild and dose-related.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Tingling in extremities — uncommon, dose-related at very high intake.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">No documented serious adverse events at standard supplemental doses across the human RCT base.</li>
          </ol>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">Less common (watch-list)</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Kidney stress at high chronic doses (1,500+ mg/day for months) — modest signal in some studies. Stay within recommended ranges; users with kidney disease should defer to nephrologist.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Mild antiplatelet effect — relevant for surgery (1-2 week pre-op washout) and chronic anticoagulant users.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Cytochrome P450 inhibition — affects metabolism of multiple medications; clinically meaningful for narrow-therapeutic-index drugs.</li>
          </ol>
        </div>
        <div>
          <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">Drug and supplement interactions</h3>
          <ol className="list-decimal list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Cyclosporine (immunosuppressant).</span> Quercetin inhibits cyclosporine metabolism — can elevate cyclosporine levels and increase toxicity risk. Coordinate with prescribing clinician.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Anticoagulants (warfarin, apixaban, rivaroxaban).</span> Mild additive antiplatelet effect. Monitor for unusual bleeding.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Quinolone antibiotics (ciprofloxacin, levofloxacin).</span> Quercetin can reduce quinolone effectiveness by competing for DNA gyrase binding. Separate dosing by 2+ hours.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">CYP3A4 / CYP2C9 substrates.</span> Quercetin inhibits these cytochrome P450 enzymes; may affect metabolism of statins, calcium channel blockers, midazolam, warfarin. Coordinate with clinician for chronic high-dose use.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Chemotherapy — quercetin has both pro- and anti-cancer effects depending on context; coordinate with oncologist.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Pregnancy and breastfeeding — insufficient supplemental-dose data; defer to clinician. Dietary intake from food is fine.</li>
          </ol>
        </div>
      </div>
    ),
  },
  {
    id: "limitations",
    title: "What we don't know yet about quercetin",
    intro:
      "Quercetin has multiple promising mechanism arms but the clinical-outcome evidence base is mixed — particularly around bioavailability-driven variability, senolytic protocol optimization, and the gap between mechanistic preclinical case and human RCT outcomes.",
    node: (
      <div className="space-y-3">
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Bioavailability-driven outcome variability.</span> Most negative or null quercetin trials used standard low-bioavailability quercetin where serum levels didn&apos;t reach effective concentrations. The pattern is similar to curcumin — formulation choice may matter more than dose. Whether Quercefit or isoquercetin produce consistently larger clinical effects than standard quercetin at equivalent serum levels is mechanistically plausible but not rigorously head-to-head tested at scale.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Senolytic protocol optimization.</span> The Mayo Clinic D+Q (dasatinib + quercetin) pilot trials are foundational but small (n=9–14). Optimal dose, frequency, and duration of pulsed senolytic protocols aren&apos;t precisely characterized. Whether quercetin standalone (without dasatinib) produces meaningful senescent-cell clearance is less clear.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Healthy young-adult longevity transfer.</span> The senolytic case is built on age-related disease populations and older adults with measurable senescent-cell burden. Whether quercetin produces meaningful longevity benefit in healthy young adults with intact cellular biology is mechanistically uncertain.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Antiviral clinical outcomes.</span> Mechanism (zinc ionophore) is strong; clinical outcomes data in specific viral infections is mixed and methodology variable. The COVID-19 trial cycle (2020–2022) didn&apos;t produce definitive answers. Honest framing: mechanism-backed adjunct, not standalone antiviral.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Long-term safety at high doses.</span> Most trial data extends to 8–12 weeks. Multi-year continuous use at 1,000+ mg/day is reasonable based on dietary culinary precedent but not directly RCT-characterized. Kidney signal at very high chronic doses warrants attention.
        </p>
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold">Cancer context dual role.</span> Quercetin shows preclinical anti-cancer effects but can interact with chemotherapy in context-specific ways. Cytochrome P450 inhibition adds another layer of drug-interaction concern for cancer patients on multiple medications.
        </p>
      </div>
    ),
  },
  {
    id: "where-to-buy",
    title: "Where to buy quercetin",
    intro:
      "Quercetin is widely available over-the-counter. Quality variation is large for this supplement — primarily because bioavailability differences between standard and phytosome formulations are 10–20×, making formulation choice the dominant practical quality marker. The screen below is what we use before clicking through.",
    node: (
      <div className="space-y-4">
        <div className="rounded-xl p-5 bg-gray-50 dark:bg-[#1e293b] border border-gray-100 dark:border-slate-700">
          <p className="text-xs font-semibold uppercase tracking-wider text-gray-500 dark:text-slate-400 mb-3">Quality markers to look for</p>
          <ul className="list-disc list-inside space-y-1">
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Quercefit phytosome (Indena)</span> — patented phytosome formulation with trial-validated absorption (~20× standard). Best evidence-supported form.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Isoquercetin</span> — glucoside form with ~3× absorption via SGLT1. Middle-cost option with better absorption than standard.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Standard quercetin + bromelain</span> — cheaper option; bromelain enhances absorption via proteolytic action. Acceptable budget choice at higher gram-doses.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Avoid plain standard quercetin without bromelain or bioavailability formulation</span> — poor absorption; essentially placebo at typical supplemental doses.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Quercetin + zinc + bromelain blend</span> — common immune-support / antiviral formulation. Reasonable for the antiviral use case.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Third-party tested</span> — USP, NSF, or ConsumerLab certifications signal independent verification.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">cGMP-certified manufacturing facility</span> — minimum bar for any supplement.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">No proprietary blends</span> that obscure the actual quercetin dose alongside fillers.</li>
            <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed"><span className="font-semibold">Fresh manufacture date</span> — flavonoids degrade with prolonged storage and light exposure.</li>
          </ul>
        </div>
        <AmazonCTAButton href="https://www.amazon.com/s?k=quercetin+phytosome&tag=profpeptide-20" label="Quercetin" />
        <p className="text-sm text-gray-500 dark:text-slate-400 leading-relaxed">
          Amazon affiliate link — Prof. Peptide earns a small commission on qualifying purchases at no extra cost to you. We use commissions to fund research and editorial work.
        </p>
      </div>
    ),
  },
  {
    id: "faq",
    title: "Quercetin FAQ",
    node: (
      <div className="space-y-4">
        {faqs.map((f, i) => (
          <div key={i}>
            <h3 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-1">
              {f.q}
            </h3>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
              {f.a}
            </p>
          </div>
        ))}
      </div>
    ),
  },
  {
    id: "references",
    title: "References",
    node: (
      <ol className="list-decimal list-inside space-y-2">
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554-563.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/30616998/" target="_blank" rel="noopener noreferrer" className="text-[#3A759F] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/30616998/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446-456.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/31542391/" target="_blank" rel="noopener noreferrer" className="text-[#3A759F] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/31542391/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Serban MC, Sahebkar A, Zanchetti A, et al. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(7):e002713.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/27405810/" target="_blank" rel="noopener noreferrer" className="text-[#3A759F] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/27405810/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Hussain SA, Sulaiman AA, Alhaddad H, Alhadidi Q. Quercetin: a promising flavonoid for therapeutic interventions in aging and age-related diseases. Curr Pharm Des. 2021;27(43):4392-4406.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/33023444/" target="_blank" rel="noopener noreferrer" className="text-[#3A759F] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/33023444/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Mlcek J, Jurikova T, Skrovankova S, Sochor J. Quercetin and its anti-allergic immune response. Molecules. 2016;21(5):623.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/27187333/" target="_blank" rel="noopener noreferrer" className="text-[#3A759F] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/27187333/
          </a>
        </li>
        <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-536.{" "}
          <a href="https://pubmed.ncbi.nlm.nih.gov/32686219/" target="_blank" rel="noopener noreferrer" className="text-[#3A759F] hover:underline break-words">
            https://pubmed.ncbi.nlm.nih.gov/32686219/
          </a>
        </li>
      </ol>
    ),
  },
  {
    id: "studies",
    title: "Published Studies",
    node: (
      <div className="space-y-6">
        <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
          Plain-English summaries of the peer-reviewed studies behind the claims above. Click any title to read the source paper.
        </p>
        {studies.map((s, i) => (
          <div key={i} className="border border-gray-100 dark:border-slate-700 rounded-xl p-5 hover:border-[#3A759F] transition-colors">
            <div className="flex flex-wrap items-center gap-2 mb-2">
              <span className="text-xs text-gray-400 dark:text-slate-500">{s.journal} &middot; {s.year}</span>
              <span className={`text-xs px-2 py-0.5 rounded-full font-medium ${s.access === "Open Access" ? "bg-green-50 text-green-700 border border-green-200" : "bg-gray-100 dark:bg-slate-700 text-gray-500 dark:text-slate-400"}`}>{s.access}</span>
            </div>
            <a href={s.url} target="_blank" rel="noopener noreferrer" className="text-lg font-semibold text-[#16181B] dark:text-slate-100 hover:text-[#3A759F] transition-colors leading-snug block mb-1">{s.title} &rarr;</a>
            <p className="text-xs text-gray-400 dark:text-slate-500 mb-3">{s.authors}</p>
            <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">{s.summary}</p>
          </div>
        ))}
      </div>
    ),
  },
];

const tocSections = sections.map((s) => ({ id: s.id, title: s.title }));

const faqPageSchema = {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What's a senolytic, and is quercetin actually one?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Senolytics are compounds that selectively kill senescent cells — the 'zombie cells' that accumulate with age, resist normal apoptosis, and release a toxic inflammatory cocktail (SASP — senescence-associated secretory phenotype) that drives age-related tissue dysfunction. Quercetin is one of the most-studied natural senolytics, typically paired with the prescription drug dasatinib (D+Q combination) in Mayo Clinic aging-research protocols. As a standalone senolytic at typical supplemental doses, quercetin's effect is modest; the D+Q combination is what produces measurable senescent-cell clearance in human pilot trials."
      }
    },
    {
      "@type": "Question",
      "name": "Standard quercetin vs phytosome vs isoquercetin — which form?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Bioavailability is the central practical issue, similar to curcumin. Standard quercetin has poor oral absorption — single-digit percent bioavailability. Quercetin phytosome (Quercefit) absorbs ~20× better than standard. Isoquercetin (the glucoside form found in onions and other foods) absorbs ~3× better than standard via SGLT1 transporter. Practical default: Quercefit phytosome for senolytic and longevity protocols where serum quercetin matters; isoquercetin as a middle-cost option; standard quercetin powder is essentially placebo at typical supplemental doses."
      }
    },
    {
      "@type": "Question",
      "name": "How much quercetin should I take?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Depends on goal and form. For general anti-inflammatory and antihistamine use: 500–1,000 mg/day of Quercefit phytosome (or 1,500–2,500 mg/day standard quercetin with bromelain). For senolytic protocols: the Mayo Clinic D+Q pilot used dasatinib 100 mg + quercetin 1,000 mg for 2 consecutive days, repeated every 2 weeks (intermittent rather than daily). For cardiovascular/blood pressure use: 500 mg/day phytosome shows benefit per meta-analyses. Antiviral protocols typically use 500–1,000 mg/day phytosome plus 15–30 mg elemental zinc."
      }
    },
    {
      "@type": "Question",
      "name": "Why pair quercetin with zinc and bromelain?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Two different reasons. Zinc + quercetin pairing leverages quercetin's zinc ionophore mechanism — quercetin facilitates zinc transport across cell membranes, increasing intracellular zinc concentrations. Zinc inhibits RNA-dependent RNA polymerase used by many viruses for replication, which is the mechanistic basis for the antiviral pairing. Bromelain + quercetin pairing improves quercetin's oral absorption — bromelain (a pineapple-derived protease) enhances bioavailability through proteolytic action in the gut."
      }
    },
    {
      "@type": "Question",
      "name": "Can I stack quercetin with KPV for anti-inflammatory effects?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes — the stack is mechanistically natural for users targeting comprehensive inflammation modulation. KPV (lysine-proline-valine, the C-terminal tripeptide of α-MSH) is an anti-inflammatory peptide that reduces tissue inflammation via melanocortin pathway and MC1R/MC5R receptor binding — particularly useful for gut inflammation, IBD adjunct support, and topical skin applications. Quercetin operates at a different layer: NF-κB and NLRP3 inflammasome inhibition reduce systemic inflammatory gene expression, plus senolytic clearance of pro-inflammatory senescent cells. Mechanistically complementary, no known negative interactions."
      }
    },
    {
      "@type": "Question",
      "name": "Quercetin for allergies — does it really work?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, with modest but real evidence. Quercetin inhibits histamine release from mast cells and reduces inflammatory mediator production in allergic responses. Several small trials show modest improvements in seasonal allergic rhinitis symptoms with 500–1,000 mg/day, particularly when paired with bromelain. Effect sizes are smaller than for second-generation antihistamines (cetirizine, fexofenadine, loratadine) — quercetin won't replace those for moderate-to-severe allergies. As an adjunct for users with mild allergies or seeking a more natural approach, quercetin is a reasonable trial."
      }
    },
    {
      "@type": "Question",
      "name": "Is the antiviral zinc-ionophore claim real?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Mechanistically yes; clinically uncertain. Quercetin demonstrably facilitates zinc transport into cells in vitro, and zinc inhibits viral RNA-dependent RNA polymerase. The mechanism is biochemically established. Clinical outcomes data in humans for specific viral infections (including the high-profile COVID-19 research from 2020–2022) is mixed — some positive small trials, some null. The honest framing: quercetin + zinc is a mechanism-backed antiviral adjunct with thinner clinical evidence than the marketing suggests."
      }
    },
    {
      "@type": "Question",
      "name": "How long does it take to notice quercetin's effects?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Anti-inflammatory and antihistamine effects: typically 1–2 weeks of consistent dosing. Blood pressure effects: 4–6 weeks per meta-analyses. Senolytic protocols are intermittent (not daily) and the cellular clearance effects emerge over months of repeated 2-day-on cycles. Standalone subjective effects are mild for most users — quercetin is more of a background longevity/inflammation modulator than a stimulant or fast-acting compound."
      }
    }
  ]
};

const articleSchema = {
  "@context": "https://schema.org",
  "@type": "Article",
  "headline": "Quercetin: Senolytic Flavonoid + Zinc Ionophore Anti-Inflammatory",
  "description": "Quercetin dosing, bioavailability (phytosome > standard), the senolytic dasatinib + quercetin combination, and how it stacks with anti-inflammatory peptides like KPV.",
  "url": "https://profpeptide.com/supplements/quercetin",
  "datePublished": "2026-04-07T00:00:00Z",
  "dateModified": "2026-05-26T00:00:00Z",
  "author": {
    "@type": "Organization",
    "name": "Prof. Peptide Editorial Team",
    "url": "https://profpeptide.com/about"
  },
  "reviewedBy": {
    "@type": "Organization",
    "name": "Prof. Peptide Editorial Team",
    "url": "https://profpeptide.com/about"
  },
  "publisher": {
    "@type": "Organization",
    "name": "Prof. Peptide",
    "url": "https://profpeptide.com"
  }
};

const breadcrumbSchema = {
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://profpeptide.com" },
    { "@type": "ListItem", "position": 2, "name": "Supplements", "item": "https://profpeptide.com/supplements" },
    { "@type": "ListItem", "position": 3, "name": "Quercetin" }
  ]
};

export default function QuercetinPage() {
  return (
    <>
      <JsonLd data={articleSchema} />
      <JsonLd data={breadcrumbSchema} />
      <JsonLd data={faqPageSchema} />
    <div className="section max-w-3xl">
      <Link href="/supplements" className="text-sm text-[#3A759F] hover:underline mb-6 inline-block">&larr; Back to Supplement Library</Link>

      <div className="flex flex-wrap items-center gap-3 mb-2">
        <h1 className="text-3xl font-bold text-[#16181B] dark:text-slate-100">Quercetin</h1>
        <span className="tag">Longevity</span>
      </div>
      <p className="text-sm text-gray-500 dark:text-slate-400 mb-2">
        Last reviewed: May 26, 2026
      </p>
      <div className="mb-8 p-4 bg-gray-50 dark:bg-[#1e293b] border border-gray-100 dark:border-slate-700 rounded-xl">
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
          <span className="font-semibold text-[#16181B] dark:text-slate-100">Also Known As:</span> Quercetin dihydrate, Quercefit (phytosome), isoquercetin, quercetin glucoside
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed pt-1">
          <span className="font-semibold text-[#16181B] dark:text-slate-100">Supplement Class:</span> Flavonoid polyphenol / senolytic (selective clearance of senescent cells) / NF-κB + NLRP3 inflammasome inhibitor / zinc ionophore / mast cell stabilizer
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed pt-1">
          <span className="font-semibold text-[#16181B] dark:text-slate-100">Evidence Tier:</span> Moderate — Serban 2016 meta-analysis (7 RCTs, n=587) for blood pressure reduction; Justice 2019 + Hickson 2019 first-in-human senolytic pilot trials (D+Q combination); Mlcek 2016 review for antihistamine mechanism. Senolytic and antiviral arms have strong mechanism + small/mixed clinical trial data. Strongly formulation-dependent (bioavailability gates outcomes).
        </p>
      </div>

      <div id="overview" className="scroll-mt-20">
        <h2 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">What is quercetin?</h2>
        <div className="space-y-4">
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            Quercetin is a flavonoid polyphenol found abundantly in onions, apples, capers, berries, leafy greens, and green tea — making it one of the most widely consumed dietary polyphenols. Its supplement profile spans multiple distinct mechanism arms: senolytic activity (selective clearance of senescent &ldquo;zombie&rdquo; cells, particularly potent when combined with the prescription drug dasatinib — the Mayo Clinic D+Q protocol), NF-κB and NLRP3 inflammasome inhibition (broad anti-inflammatory effect), mast cell stabilization (antihistamine), zinc ionophore activity (antiviral implications), and AMPK activation / mTOR inhibition (longevity-pathway modulation). The senolytic arm is the most mechanistically novel — Hickson 2019 documented actual senescent-cell clearance in human skin and adipose tissue biopsies after pulsed D+Q dosing, supporting the &ldquo;senolytic clearance&rdquo; framework that drives modern aging research. The cardiovascular/blood pressure arm has the cleanest meta-analytic support (Serban 2016, -3.04 mmHg SBP / -2.63 mmHg DBP). The central practical issue is bioavailability — standard quercetin has poor oral absorption (single-digit percent); Quercefit phytosome (~20× absorption) and isoquercetin (~3×) are the practical solutions. Quercetin pairs naturally with{" "}
            <Link href="/peptides/kpv" className="text-[#3A759F] hover:underline">anti-inflammatory peptides like KPV</Link>{" "}
            for inflammation modulation, and with{" "}
            <Link href="/peptides/nad-plus" className="text-[#3A759F] hover:underline">NAD+ peptide / Epitalon</Link>{" "}
            for longevity-cluster protocols.
          </p>
          <div>
            <p className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">
              Reported benefits:
            </p>
            <ul className="list-disc list-inside space-y-1">
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Senolytic clearance of senescent cells (Hickson 2019 in human skin/adipose biopsies after D+Q)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Functional improvements in idiopathic pulmonary fibrosis (Justice 2019 D+Q pilot)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Modest blood pressure reduction (-3.04 mmHg SBP / -2.63 mmHg DBP per Serban 2016 meta-analysis)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Anti-inflammatory biomarker reduction (CRP, IL-6, TNF-α)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Antihistamine effect for seasonal allergic rhinitis (modest but real)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">Zinc ionophore mechanism for antiviral adjunct (mechanism strong; clinical outcomes mixed)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">NF-κB and NLRP3 inflammasome inhibition (broad anti-inflammatory)</li>
              <li className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">AMPK activation + mTOR inhibition (longevity-pathway modulation)</li>
            </ul>
          </div>
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            <span className="font-semibold text-[#16181B] dark:text-slate-100">Common dose:</span> Quercefit phytosome 250–500 mg twice daily (trial-validated for blood pressure and anti-inflammatory effects); isoquercetin 500–1,000 mg/day; standard quercetin + bromelain 1,000–2,000 mg + 100–500 mg bromelain daily. Always with fat-containing meals. Senolytic D+Q protocol is intermittent (pulsed 2–3 days every 2 weeks) and requires prescription dasatinib.
          </p>
          <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
            <span className="font-semibold text-[#16181B] dark:text-slate-100">Pre-surgical washout:</span> Stop quercetin 1–2 weeks before scheduled surgery — mild antiplatelet effect plus cytochrome P450 enzyme interference affects other drug metabolism. Important for users on cyclosporine, warfarin, or narrow-therapeutic-index medications.
          </p>
          <AmazonCTAButton href="https://www.amazon.com/s?k=quercetin+phytosome&tag=profpeptide-20" label="Quercetin" />
        </div>
      </div>

      <PageTOC sections={tocSections} />

      <div className="space-y-8">
        {sections.map((s) => (
          <div key={s.id} id={s.id} className="scroll-mt-20">
            <h2 className="text-lg font-semibold text-[#16181B] dark:text-slate-100 mb-2">
              {s.title}
            </h2>
            {s.intro && (
              <p className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed mb-4">
                {s.intro}
              </p>
            )}
            {s.node && s.node}
            {s.body && (
              <ol className="list-decimal list-inside space-y-1">
                {s.body.map((item, i) => (
                  <li key={i} className="text-lg text-gray-600 dark:text-slate-300 leading-relaxed">
                    {item}
                  </li>
                ))}
              </ol>
            )}
          </div>
        ))}
      </div>

      <div className="flex flex-wrap gap-2 mt-8">
        {["Senolytic", "Zinc Ionophore", "NLRP3 Inhibitor", "Mayo Clinic D+Q", "Quercefit", "Anti-Histamine"].map((tag) => (
          <span key={tag} className="text-xs bg-gray-100 dark:bg-slate-700 text-gray-500 dark:text-slate-400 px-2.5 py-1 rounded-full">{tag}</span>
        ))}
      </div>

      <div className="mt-6 p-5 bg-gray-50 dark:bg-[#1e293b] border border-gray-100 dark:border-slate-700 rounded-xl">
        <h2 className="text-sm font-semibold text-[#16181B] dark:text-slate-100 mb-2">Related Supplements</h2>
        <div className="flex flex-wrap gap-4">
          <Link href="/supplements/zinc" className="text-sm font-medium text-[#3A759F] hover:underline">Zinc</Link>
          <Link href="/supplements/resveratrol" className="text-sm font-medium text-[#3A759F] hover:underline">Resveratrol</Link>
          <Link href="/supplements/spermidine" className="text-sm font-medium text-[#3A759F] hover:underline">Spermidine</Link>
          <Link href="/supplements/nmn" className="text-sm font-medium text-[#3A759F] hover:underline">NMN</Link>
          <Link href="/supplements/curcumin" className="text-sm font-medium text-[#3A759F] hover:underline">Curcumin</Link>
          <Link href="/supplements/coq10" className="text-sm font-medium text-[#3A759F] hover:underline">CoQ10</Link>
        </div>
      </div>

      <PageDisclaimer />
    <ContactLink pageName="Quercetin" pagePath="/supplements/quercetin" />
    </div>
    </>
  );
}
